This Antibody was verified by Neutralization to ensure that the antibody binds to the antigen stated.
In direct ELISAs, approximately 20% cross-reactivity with recombinant human (rh) VEGF165 and rhVEGF121 is observed and less than 2% cross-reactivity with rhVEGF-B, recombinant mouse (rm) VEGF-B, rhVEGF-C, rhVEGF-D, and rmVEGF-D is observed.
Reconstitute at 0.2 mg/mL in sterile PBS.
Endoxin level is <0.10 EU per 1 µg of the antibody by the LAL method.
VEGF-164 is a gene target that encodes for the vascular endothelial growth factor. This protein is responsible for promoting angiogenesis. VEGF-164 has been shown to be involved in the development of various diseases, including cancer, cardiovascular disease, and diabetic retinopathy. Targeting this gene has become an important strategy in the development of new therapeutics for these conditions.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Protein Aliases: Vascular endothelial growth factor A; Vascular permeability factor; VEGF-A; VPF
Gene Aliases: Vegf; VEGF-A; VEGF164; Vegfa; VPF
UniProt ID: (Rat) P16612
Entrez Gene ID: (Rat) 83785
Molecular Function: growth factor